Skip to content

Effect of Oxycodone Injection Administered at Different Time Points on Postoperative Catheter-Related Bladder Discomfort (CRBD) in Patients Undergoing Ureteroscopic Lithotripsy

Effect of Oxycodone Injection Administered at Different Time Points on Postoperative Catheter-Related Bladder Discomfort (CRBD) in Patients Undergoing Ureteroscopic Lithotripsy

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119440
Enrollment
Unknown
Registered
2026-02-27
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheter-related bladder discomfort (CRBD)

Interventions

Group B:Oxycodone (0.1 mg/kg) was administered 10 minutes prior to surgical conclusion
Group A:Oxycodone (0.1 mg/kg) was administered 10 minutes prior to surgical conclusion to prevent postoperative CRBD.

Sponsors

The Second Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Undergoing primary ureteroscopic laser lithotripsy under general anesthesia. 2. American Society of Anesthesiologists (ASA) physical status classification of I to III. 3. Aged between 18 and 65 years. 4. Body mass index (BMI) ranging from 18 to 30 kg/m². 5. Having fully understood the trial protocol and provided written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with contraindications to general anesthesia. 2. Known allergy to oxycodone or any other component of the study medication. 3. Severe systemic diseases (e.g., moderate to severe hepatic impairment; severe renal impairment). 4. Other contraindications to opioid use. 5. History of chronic heavy alcohol use. 6. Anatomical abnormalities leading to difficult laryngeal mask airway placement. 7. Communication barriers that would preclude effective postoperative follow-up.

Design outcomes

Primary

MeasureTime frame
The incidence of CRBD within 4 hours after surgery.;

Secondary

MeasureTime frame
Operative Time, Time to Emergence (from anesthesia), Incidence of Adverse Events (AEs), Patient Satisfaction;Visual Analog Scale;Ramsay;

Countries

China

Contacts

Public ContactLi Zhisong

The Second Affiliated Hospital of Zhengzhou University

lzszd@126.com+86 137 8357 3974

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026